Active Ingredient History
Magnesium aspartate dihydrate is one of the most absorbable forms of magnesium. It is used as a source of magnesium in dietary foods for special medical purposes, was not of safety concern at the established levels of usage and that there would be no safety concern from aspartate at the established usage levels. Magnesium is often suggested to be taken with calcium supplements. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Gastrointestinal Diseases (approved 2016)
Pre-Eclampsia (approved 1995)
Alcoholic Intoxication (Phase 4)
Analgesia (Phase 4)
Arrhythmias, Cardiac (Phase 2)
Atrial Fibrillation (Phase 3)
Autism Spectrum Disorder (Phase 2)
beta-Thalassemia (Phase 2)
Bipolar Disorder (Phase 2)
Blood Loss, Surgical (Phase 4)
Brain Neoplasms (Phase 2)
Burns (Phase 4)
Cataract (Phase 2)
Colon (Phase 3)
Colorectal Neoplasms (Phase 3)
Colorectal Surgery (Phase 4)
Conjunctivitis, Bacterial (Phase 4)
Depression (Phase 2/Phase 3)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 1)
Diabetes Mellitus, Type 2 (Phase 3)
Diabetic Retinopathy (Phase 2)
Dyslipidemias (Phase 2/Phase 3)
Eclampsia ()
Epiretinal Membrane (Phase 4)
Fibromyalgia (Phase 2)
Glaucoma (Phase 2/Phase 3)
Glaucoma, Neovascular (Phase 2)
Glaucoma, Open-Angle (Phase 2)
Glioma (Phase 2)
Healthy Volunteers (Phase 1)
Heart Septal Defects, Atrial (Phase 3)
Heart Septal Defects, Ventricular (Phase 3)
Hypertension (Phase 4)
Hypertrophy, Left Ventricular (Phase 3)
Hypovolemia (Phase 4)
Inflammation (Phase 4)
Ischemic Stroke (Phase 1)
Kidney Failure, Chronic (Phase 2)
Lymphoma (Early Phase 1)
Magnesium Deficiency (Phase 4)
Migraine Disorders (Phase 4)
Molar, Third (Phase 1/Phase 2)
Obesity (Phase 2/Phase 3)
Osteoporosis (Phase 3)
Pain (Phase 4)
Pain, Postoperative (Phase 4)
Pancreatic Neoplasms (Phase 4)
Parkinson Disease (Phase 2/Phase 3)
Peritonitis (Phase 4)
Pharmacology (Phase 2)
Plasma (Phase 4)
Pneumonia (Phase 4)
Postoperative Complications (Phase 3)
Psoriasis (Phase 1)
Psychological Distress (Phase 2)
Renal Insufficiency, Chronic (Phase 2)
Seizures ()
Sepsis (Phase 4)
Spinal Diseases (Phase 4)
Spinal Stenosis (Phase 4)
Stroke (Phase 3)
Tissue Adhesions (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue